Protalix BioTherapeutics PLX
NYSE PLX
$2.57 -0.07 (-2.65%)
As of: Oct 21, 2026 · 3:59 PM EDT

Protalix BioTherapeutics (PLX) Total Current Liabilities (2010 - 2026)

Updated

Protalix BioTherapeutics' Total Current Liabilities was $31.39 million in Q2 2026, up 30.3% from $24.09 million a year earlier and up 14.6% from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Protalix BioTherapeutics came in at $26.52 million, up 3.5% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of -21.1% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $25.62 million in FY2024 (-43.7%), $45.53 million in FY2023 (+40.4%), $32.43 million in FY2022 (-2.3%) and $33.18 million in FY2021 (-61.6%).
  • The Q2 2026 figure marks the highest quarterly Total Current Liabilities since Q2 2024.
  • Compared with a year earlier, Total Current Liabilities has increased for three straight quarters, with an average decline of 20.6% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q2 2024 (growth of 150.9%); the worst was Q2 2022 (a decline of 67.8%).
  • Per Business Quant data, PLX's Total Current Liabilities in the three quarters before Q2 2026 was $27.39 million (Q1 2026), $26.52 million (Q4 2025) and $21.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Protalix BioTherapeutics 207.16 Mn 55.78 Mn 12.13 Mn 31.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.39 Mn
Mar 31, 2026 27.39 Mn
Dec 31, 2025 26.52 Mn
Sep 30, 2025 21.95 Mn
Jun 30, 2025 24.09 Mn
Mar 31, 2025 24.32 Mn
Dec 31, 2024 25.62 Mn
Sep 30, 2024 24.22 Mn
Jun 30, 2024 57.97 Mn
Mar 31, 2024 54.83 Mn
Dec 31, 2023 45.53 Mn
Sep 30, 2023 43.36 Mn
Jun 30, 2023 23.11 Mn
Mar 31, 2023 31.52 Mn
Dec 31, 2022 32.43 Mn
Sep 30, 2022 34.30 Mn
Jun 30, 2022 30.96 Mn
Mar 31, 2022 35.33 Mn
Dec 31, 2021 33.18 Mn
Sep 30, 2021 42.76 Mn
API Access

Protalix BioTherapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PLX&period=max&api_key=YOUR_API_KEY